Hem › Juvenil myelomonocyt leukemi › Massachusetts
Kliniska studier för Juvenil myelomonocyt leukemi i Massachusetts
3 studier för Juvenil myelomonocyt leukemi söker deltagare vid platser i Massachusetts.
Städer i Massachusetts
Officiell studietext (engelska)
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- Dana-Farber Cancer Institute, Boston
RekryterarFas 1
Ålder 1 till 18 · Alla kön · Uppdaterad 25 aug. 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dana-Farber Cancer Institute, Boston
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Boston Children's Hospital, Boston
- Dana Farber Cancer Institute, Boston
RekryterarFas 1
Ålder 12 och äldre · Alla kön · Uppdaterad 17 juni 2026 · NCT04024761Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.